Postoperative lung cancer relapse after chemoradiation therapy

D. Subotic (Belgrade, Republic of Serbia)

Source: International Congress 2014 – Thoracic oncology grand round - an interactive session
Session: Thoracic oncology grand round - an interactive session
Session type: Grand round
Number: 3372
Disease area: Thoracic oncology

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Subotic (Belgrade, Republic of Serbia). Postoperative lung cancer relapse after chemoradiation therapy. International Congress 2014 – Thoracic oncology grand round - an interactive session

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011


Long-term follow-up comparing postoperative chemotherapy or radiotherapy and surgery with surgery alone in resectable nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 131s
Year: 2001

Impact of neoadjuvant therapies on surgical indications and early postoperative outcome
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour
Source: Eur Respir J 2007; 29: 117-126
Year: 2007



Optimising treatment for post-operative lung cancer recurrence
Source: Eur Respir J 2016; 47: 374-378
Year: 2016


Survival and postoperative complication after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer: a balancing exercise
Source: Eur Respir J 2003; 22: Suppl. 45, 31s
Year: 2003

Survival of elderly patients with non-small lung cancer tretaed with combined chemotherapy and radiotherapy
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005


Pre-operative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage nonsmall cell lung cancer
Source: Breathe 2010; 7: 196-197
Year: 2010

Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Cryotherapy as an adjuvant to radiotherapy in lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 76s
Year: 2005

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Eur Respir J 2009; 34: 17-41
Year: 2009



Is there any place for perioperative radiation therapy?
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011


Adjuvant and neoadjuvant therapy in nonsmall cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Clinical year in review
Year: 2006


Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 478s
Year: 2004

Adjuvant therapy in NSCLC
Source: Annual Congress 2007 - Clinical year in review
Year: 2007


Changes of diffusing capacity after neoadjuvant concurrent chemoradiotherapy: implication on postoperative pulmonary complications in non-small cell lung cancer patients
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018



Thromboembolic events in lung cancer patients treated with platinum-based chemotherapy
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019